EWTX · Insider trading · 13F holders · Congress trades
Edgewise Therapeutics, Inc. (EWTX)
Who is buying and selling EWTX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 31
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $1.9M
- Congress trades, 12 months
- 0
EWTX at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 5 EWTX insiders filed 5 sales worth $1.9M on SEC Form 4, and no open-market purchases; 1 of the sales were pre-planned under Rule 10b5-1.
- 31 13F filers hold EWTX among their 50 largest positions, worth $2.8B combined, including Peter Kolchinsky, Joseph Edelman and Julian and Felix Baker. The biggest bets by portfolio weight are Novo Holdings A/s (12.6%), Orbimed Advisors LLC (12.0%) and Paradigm Biocapital Advisors LP (7.8%). In their latest 13Fs, 1 manager opened a new position and 7 added to one.
- No member of Congress has disclosed a trade in EWTX.
- EWTX last closed at $38.91 on Oct 29, 2026.
EWTX insider trading
Between Aug 1, 2026 and Oct 29, 2026, 5 EWTX insiders filed 5 sales worth $1.9M on SEC Form 4, and no open-market purchases; 1 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Koch Kevin | President and CEO, Director | Sale | 17,971 | $43.68 | $785K | SEC |
| Aug 14, 2026 | Donovan Joanne M. | CMO | Sale10b5-1 | 9,441 | $43.71 | $413K | SEC |
| Aug 14, 2026 | Russell Alan J | Chief Scientific Officer, Director | Sale | 5,901 | $43.73 | $258K | SEC |
| Aug 14, 2026 | Derakhshan Behrad | Chief Business Officer | Sale | 5,100 | $43.81 | $223K | SEC |
| Aug 14, 2026 | Moore John R | General Counsel | Sale | 5,016 | $43.82 | $220K | SEC |
Who owns EWTX? Hedge funds and superinvestors
31 13F filers hold EWTX among their 50 largest positions, worth $2.8B combined, including Peter Kolchinsky, Joseph Edelman and Julian and Felix Baker. The biggest bets by portfolio weight are Novo Holdings A/s (12.6%), Orbimed Advisors LLC (12.0%) and Paradigm Biocapital Advisors LP (7.8%). In their latest 13Fs, 1 manager opened a new position and 7 added to one.
Superinvestors holding EWTX: Peter Kolchinsky 3.0% · Joseph Edelman 2.8% · Julian and Felix Baker 0.8%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Orbimed Advisors LLCHedge fund | 12.0% | $630.5M | 15,518,492 | +0.0% shares | Q2 2026 |
| Paradigm Biocapital Advisors LPHedge fund | 7.8% | $415.1M | 10,215,455 | +38.7% shares | Q2 2026 |
| Peter KolchinskyHedge fund | 3.0% | $341.0M | 8,392,730 | -19.5% shares | Q2 2026 |
| Novo Holdings A/sInvestment manager | 12.6% | $217.4M | 5,350,000 | +0.0% shares | Q2 2026 |
| Driehaus Capital Management LLCHedge fund | 1.1% | $192.1M | 4,728,623 | +5.6% shares | Q2 2026 |
| Joseph EdelmanHedge fund | 2.8% | $177.7M | 4,373,974 | -1.1% shares | Q2 2026 |
| Julian and Felix BakerHedge fund | 0.8% | $150.4M | 3,701,719 | -43.7% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 2.6% | $129.4M | 3,184,629 | -28.1% shares | Q2 2026 |
| Cormorant Asset Management, LPHedge fund | 5.2% | $102.0M | 2,510,000 | -23.0% shares | Q2 2026 |
| Integral Health Asset Management, LLCHedge fund | 3.3% | $81.3M | 2,000,000 | +25.0% shares | Q2 2026 |
| Braidwell LPHedge fund | 3.1% | $81.1M | 1,996,965 | -14.9% shares | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 4.0% | $65.9M | 1,620,780 | -2.4% shares | Q2 2026 |
| First Light Asset Management, LLCHedge fund | 2.7% | $44.5M | 1,095,171 | +9.3% shares | Q2 2026 |
| Tyro Capital Management LLCHedge fund | 5.6% | $24.9M | 612,965 | New | Q2 2026 |
| Parkman Healthcare Partners LLCHedge fund | 2.4% | $23.4M | 577,036 | +78.7% shares | Q2 2026 |
| Opaleye Management Inc.Hedge fund | 1.8% | $20.3M | 500,000 | +0.0% shares | Q2 2026 |
| Soleus Capital Management, L.P.Hedge fund | 0.6% | $18.3M | 450,889 | -68.9% shares | Q2 2026 |
| Sofinnova Investments, Inc.Hedge fund | 0.8% | $15.5M | 380,923 | -1.4% shares | Q2 2026 |
| Squadron Capital Management LLCHedge fund | 4.0% | $11.8M | 290,000 | -17.1% shares | Q2 2026 |
| Diadema Partners LPHedge fund | 4.2% | $11.1M | 272,214 | — | Q2 2026 |
| DAFNA Capital Management LLCHedge fund | 1.8% | $9.2M | 226,819 | +102.1% shares | Q2 2026 |
| KVP Capital Advisors, LPHedge fund | 4.0% | $5.4M | 133,000 | +0.0% shares | Q2 2026 |
| Quantum Private Wealth, LLCWealth manager | 1.2% | $4.5M | 110,815 | -2.3% shares | Q3 2026 |
| Artia Global Partners LPHedge fund | 0.8% | $4.0M | 98,800 | +50.8% shares | Q2 2026 |
| HighVista Strategies LLCHedge fund | 0.8% | $3.7M | 90,996 | -1.0% shares | Q2 2026 |
| Ally Bridge Group (NY) LLCHedge fund | 4.4% | $3.4M | 83,300 | -48.3% shares | Q2 2026 |
| Persistent Asset Partners LtdHedge fund | 0.9% | $2.8M | 69,441 | — | Q2 2026 |
| HighMark Wealth Management LLCWealth manager | 0.7% | $2.2M | 53,179 | +0.0% shares | Q2 2026 |
| Verdad Advisers, LPAsset manager | 1.1% | $1.1M | 27,234 | — | Q2 2026 |
| Lion Point Capital, LPHedge fund | 1.8% | $370K | 9,100 | +0.0% shares | Q2 2026 |
The 30 largest of 31 positions, by value. Each manager counts with its latest 13F (Q3 2026: 2, Q2 2026: 29). Screen EWTX in the grand portfolio →
EWTX stock trades by members of Congress
No member of Congress has disclosed a trade in EWTX.
EWTX questions and answers
Are insiders buying EWTX stock?
Between Aug 1, 2026 and Oct 29, 2026, 5 EWTX insiders filed 5 sales worth $1.9M on SEC Form 4, and no open-market purchases; 1 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own EWTX?
31 13F filers hold EWTX among their 50 largest positions, worth $2.8B combined, including Peter Kolchinsky, Joseph Edelman and Julian and Felix Baker. The biggest bets by portfolio weight are Novo Holdings A/s (12.6%), Orbimed Advisors LLC (12.0%) and Paradigm Biocapital Advisors LP (7.8%). In their latest 13Fs, 1 manager opened a new position and 7 added to one.
Has Congress traded EWTX?
No member of Congress has disclosed a trade in EWTX.
Who is the largest holder of EWTX?
Among 13F filers, Orbimed Advisors LLC reports the largest EWTX position, $630.5M (15,518,492 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Novo Holdings A/s's: 12.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.